Table 4.
Patients | Area of analysis | Positive HyS | Negative HyS | ||||
HRCT(n = 18) | CTPA(n = 45) | VP(n = 15) | HRCT(n = 47) | CTPA(n = 20) | VP(n = 5) | ||
IMD 65/98 | Peripheral | 36.55 | 46.84 | 64.13 | 27.72 | 44.35 | 53.88 |
Centre | 20.22 | 21.78 | 25.20 | 20.68 | 41.44 | 51.60 | |
Difference | 16.33 | 25.06 | 38.93 | 7.04 | 2.91 | 2.28 | |
HRCT(n = 0) | CTPA(n = 1) | VP(n = 0) | HRCT(n = 33) | CTPA(n = 32) | VP(n = 13) | ||
No-IMD 33/98 | Peripheral | – | 37.03 | – | 24.85 | 54.82 | 60.92 |
Centre | – | 13.25 | – | 23.67 | 52.73 | 58.77 | |
Difference | – | 23.78 | – | 1.18 | 2.09 | 2.15 |
CTPA, CT pulmonary angiography; HRCT,high-resolution CT; HyS,hypodense sign; IMD, invasive mould disease; VP, venous phase.
The average HU values of the pulmonary lesions in peripheral zone, central zone, and the difference between peripheral and central zone, respectively on unenhanced HRCT, arterial phase (CTPA) and VP, are compared with evaluation of HyS, in both the two groups of patients, with IMD and without IMD.